# Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN

> **NCT04939480** · PHASE2 · COMPLETED · sponsor: **University Hospital, Essen** · enrollment: 20 (actual)

## Conditions studied

- Squamous Cell Carcinoma of Head and Neck

## Interventions

- **DRUG:** Atezolizumab

## Key facts

- **NCT ID:** NCT04939480
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-06
- **Primary completion:** 2024-03-14
- **Final completion:** 2024-03-14
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04939480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04939480, "Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04939480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*